Learning therapeutic lessons from metastasis suppressor proteins

[1]  Dan Theodorescu,et al.  Profiling bladder cancer organ site-specific metastasis identifies LAMC2 as a novel biomarker of hematogenous dissemination. , 2009, The American journal of pathology.

[2]  Jung Weon Lee,et al.  Transcriptional induction of DLC-1 gene through Sp1 sites by histone deacetylase inhibitors in gastric cancer cells , 2008, Experimental & Molecular Medicine.

[3]  K. Watabe,et al.  Drug development against metastasis-related genes and their pathways: a rationale for cancer therapy. , 2008, Biochimica et biophysica acta.

[4]  R. Weinberg.  Leaving home early: reexamination of the canonical models of tumor progression. , 2008, Cancer cell.

[5]  Sabine Riethdorf,et al.  Circulating Tumor Cells and Bone Marrow Micrometastasis , 2008, Clinical Cancer Research.

[6]  C. Horak,et al.  Clinical-Translational Approaches to the Nm23-H1 Metastasis Suppressor , 2008, Clinical Cancer Research.

[7]  George Poste,et al.  The "seed and soil" hypothesis revisited. , 2008, The Lancet. Oncology.

[8]  Kedar S Vaidya,et al.  BRMS1 suppresses breast cancer metastasis in multiple experimental models of metastasis by reducing solitary cell survival and inhibiting growth initiation , 2008, Clinical & Experimental Metastasis.

[9]  W. Kolch,et al.  Snail is a repressor of RKIP transcription in metastatic prostate cancer cells , 2008, Oncogene.

[10]  Kedar S Vaidya,et al.  BRMS1 suppresses breast cancer experimental metastasis to multiple organs by inhibiting several steps of the metastatic process. , 2008, The American journal of pathology.

[11]  R. Weinberg,et al.  MicroRNAs in malignant progression , 2008, Cell cycle.

[12]  Jian-hua Xu,et al.  KAI1 is a potential target for anti-metastasis in pancreatic cancer cells. , 2008, World journal of gastroenterology.

[13]  P. Steeg,et al.  Metastasis: a therapeutic target for cancer , 2008, Nature Clinical Practice Oncology.

[14]  W. Gerald,et al.  Endogenous human microRNAs that suppress breast cancer metastasis , 2008, Nature.

[15]  R. Eils,et al.  Systemic spread is an early step in breast cancer. , 2008, Cancer cell.

[16]  C. Horak,et al.  The role of metastasis suppressor genes in metastatic dormancy. , 2008, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[17]  Kedar S Vaidya,et al.  Metastasis suppressors genes in cancer. , 2008, The international journal of biochemistry & cell biology.

[18]  S. Steinberg,et al.  Nm23-H1 suppresses metastasis by inhibiting expression of the lysophosphatidic acid receptor EDG2. , 2007, Cancer research.

[19]  D. Peng,et al.  Gene delivery for lung cancer using nonviral gene vectors. , 2007, Die Pharmazie.

[20]  A. Giuliano,et al.  The Prognostic Significance of Micrometastases in Breast Cancer: A SEER Population-Based Analysis , 2007, Annals of Surgical Oncology.

[21]  P. Banerjee,et al.  Genistein induces the metastasis suppressor kangai-1 which mediates its anti-invasive effects in TRAMP cancer cells. , 2007, Biochemical and biophysical research communications.

[22]  Jae K. Lee,et al.  A strategy for predicting the chemosensitivity of human cancers and its application to drug discovery , 2007, Proceedings of the National Academy of Sciences.

[23]  P. Meltzer,et al.  Nm23-H1 suppresses tumor cell motility by down-regulating the lysophosphatidic acid receptor EDG2. , 2007, Cancer research.

[24]  E. Robertson,et al.  Epstein-Barr Virus Latent Nuclear Antigens Can Induce Metastasis in a Nude Mouse Model , 2007, Journal of Virology.

[25]  K. Cao,et al.  Biphasic expression of RhoGDI2 in the progression of breast cancer and its negative relation with lymph node metastasis. , 2007, Oncology reports.

[26]  S. Eccles,et al.  Metastasis: recent discoveries and novel treatment strategies , 2007, The Lancet.

[27]  A. Mai.  The therapeutic uses of chromatin-modifying agents , 2007, Expert opinion on therapeutic targets.

[28]  Kedar S Vaidya,et al.  Requirement of KISS1 secretion for multiple organ metastasis suppression and maintenance of tumor dormancy. , 2007, Journal of the National Cancer Institute.

[29]  N. Hattori,et al.  Adenoviral transduction of MRP-1/CD9 and KAI1/CD82 inhibits lymph node metastasis in orthotopic lung cancer model. , 2007, Cancer research.

[30]  P. Connolly,et al.  Metastin (KiSS-1) mimetics identified from peptide structure-activity relationship-derived pharmacophores and directed small molecule database screening. , 2007, Journal of medicinal chemistry.

[31]  H. Frierson,et al.  Neuromedin U is regulated by the metastasis suppressor RhoGDI2 and is a novel promoter of tumor formation, lung metastasis and cancer cachexia , 2007, Oncogene.

[32]  D. McNeel,et al.  Endothelin Receptor Antagonists in Cancer Therapy , 2007, Cancer investigation.

[33]  J. Massagué,et al.  Cancer Metastasis: Building a Framework , 2006, Cell.

[34]  A. E. Curtis,et al.  Chronic subcutaneous administration of kisspeptin-54 causes testicular degeneration in adult male rats. , 2006, American journal of physiology. Endocrinology and metabolism.

[35]  H. Dressman,et al.  Genomic signatures to guide the use of chemotherapeutics , 2006, Nature Medicine.

[36]  A. Chambers,et al.  Tumor dormancy and the role of metastasis suppressor genes in regulating ectopic growth. , 2006, Future oncology.

[37]  D. V. Von Hoff,et al.  Identification of an agent selectively targeting DPC4 (deleted in pancreatic cancer locus 4)-deficient pancreatic cancer cells. , 2006, Cancer research.

[38]  R. Shoemaker.  The NCI60 human tumour cell line anticancer drug screen , 2006, Nature Reviews Cancer.

[39]  Paul A Clemons,et al.  The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease , 2006, Science.

[40]  A. Goldhirsch,et al.  Prolonged clinical benefit with metronomic chemotherapy in patients with metastatic breast cancer , 2006, Anti-cancer drugs.

[41]  P. Steeg.  Tumor metastasis: mechanistic insights and clinical challenges , 2006, Nature Medicine.

[42]  K. Miura,et al.  Interaction of KAI1 on tumor cells with DARC on vascular endothelium leads to metastasis suppression , 2006, Nature Medicine.

[43]  G. Francini,et al.  A novel metronomic chemotherapy regimen of weekly platinum and daily oral etoposide in high-risk non-small cell lung cancer patients. , 2006, Oncology reports.

[44]  D. Theodorescu,et al.  Metastasis Suppressor Proteins: Discovery, Molecular Mechanisms, and Clinical Application , 2006, Clinical Cancer Research.

[45]  P. Clézardin,et al.  The type 1 lysophosphatidic acid receptor is a target for therapy in bone metastases. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[46]  D. Webb,et al.  Profile of Past and Current Clinical Trials Involving Endothelin Receptor Antagonists: The Novel “-Sentan” Class of Drug , 2006, Experimental biology and medicine.

[47]  Hao Wang,et al.  Inhibition of ovarian cancer metastasis by adeno-associated virus-mediated gene transfer of nm23H1 in an orthotopic implantation model , 2006, Cancer Gene Therapy.

[48]  Peter J. Keller,et al.  Metastasis suppressor gene Raf kinase inhibitor protein (RKIP) is a novel prognostic marker in prostate cancer , 2006, The Prostate.

[49]  D. Welch,et al.  The KISS1 metastasis suppressor: mechanistic insights and clinical utility. , 2006, Frontiers in bioscience : a journal and virtual library.

[50]  S. Bloom,et al.  Kisspeptin-54 stimulates the hypothalamic-pituitary gonadal axis in human males. , 2005, The Journal of clinical endocrinology and metabolism.

[51]  Karin Oien,et al.  Reduction of Raf-1 Kinase Inhibitor Protein Expression Correlates with Breast Cancer Metastasis , 2005, Clinical Cancer Research.

[52]  W. Kaelin.  The Concept of Synthetic Lethality in the Context of Anticancer Therapy , 2005, Nature Reviews Cancer.

[53]  H. Frierson,et al.  Endothelin axis is a target of the lung metastasis suppressor gene RhoGDI2. , 2005, Cancer research.

[54]  S. Goodison,et al.  The RhoGAP protein DLC-1 functions as a metastasis suppressor in breast cancer cells. , 2005, Cancer research.

[55]  C. Dermardirossian,et al.  GDIs: central regulatory molecules in Rho GTPase activation. , 2005, Trends in cell biology.

[56]  S. Steinberg,et al.  Medroxyprogesterone acetate elevation of Nm23-H1 metastasis suppressor expression in hormone receptor-negative breast cancer. , 2005, Journal of the National Cancer Institute.

[57]  J. Foekens,et al.  Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer , 2005, The Lancet.

[58]  W. Gerald,et al.  Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. , 2005, The Journal of clinical investigation.

[59]  C. Restall,et al.  Genomic analysis of a spontaneous model of breast cancer metastasis to bone reveals a role for the extracellular matrix. , 2005, Molecular cancer research : MCR.

[60]  King-Jen Chang,et al.  Connective tissue growth factor inhibits metastasis and acts as an independent prognostic marker in colorectal cancer. , 2005, Gastroenterology.

[61]  D. Richardson,et al.  Iron chelators with high antiproliferative activity up-regulate the expression of a growth inhibitory and metastasis suppressor gene: a link between iron metabolism and proliferation. , 2004, Blood.

[62]  Ying Wang,et al.  PTEN Up-Regulates the Tumor Metastasis Suppressor Gene Drg-1 in Prostate and Breast Cancer , 2004, Cancer Research.

[63]  E. Kohn,et al.  Anoikis: Cancer and the homeless cell , 2004, Nature.

[64]  Ken Saito,et al.  Role of the putative tumor metastasis suppressor gene Drg-1 in breast cancer progression , 2004, Oncogene.

[65]  Dan Theodorescu,et al.  Reduced Expression of Metastasis Suppressor RhoGDI2 Is Associated with Decreased Survival for Patients with Bladder Cancer , 2004, Clinical Cancer Research.

[66]  Robert S. Kerbel,et al.  The anti-angiogenic basis of metronomic chemotherapy , 2004, Nature Reviews Cancer.

[67]  K. Reddy,et al.  Role of MAP kinase in tumor progression and invasion , 2003, Cancer and Metastasis Reviews.

[68]  D. Welch.  Technical considerations for studying cancer metastasis in vivo , 1997, Clinical & Experimental Metastasis.

[69]  I. Fidler.  Orthotopic implantation of human colon carcinomas into nude mice provides a valuable model for the biology and therapy of metastasis , 1991, Cancer and Metastasis Reviews.

[70]  P. Steeg,et al.  MMTV-associated transcription factor binding sites increase nm23-H1 metastasis suppressor gene expression in human breast carcinoma cell lines , 2004, Clinical & Experimental Metastasis.

[71]  T. Barrette,et al.  ONCOMINE: a cancer microarray database and integrated data-mining platform. , 2004, Neoplasia.

[72]  D. Im,et al.  Ki16425, a subtype-selective antagonist for EDG-family lysophosphatidic acid receptors. , 2003, Molecular pharmacology.

[73]  Qiao Wu,et al.  Role of tumor metastasis suppressor gene KAI1 in digestive tract carcinomas and cancer cells , 2003, Cell and Tissue Research.

[74]  P. Steeg,et al.  Dexamethasone and medroxyprogesterone acetate elevate Nm23-H1 metastasis suppressor gene expression in metastatic human breast carcinoma cells: new uses for old compounds. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[75]  D Hölzel,et al.  The process of metastasisation for breast cancer. , 2003, European journal of cancer.

[76]  R. Kimberly,et al.  Synergistic induction of tumor cell apoptosis by death receptor antibody and chemotherapy agent through JNK/p38 and mitochondrial death pathway , 2003, Oncogene.

[77]  V. Robinson,et al.  Metastasis suppression: the evolving role of metastasis suppressor genes for regulating cancer cell growth at the secondary site. , 2003, The Journal of urology.

[78]  M. Rubin,et al.  Effects of raf kinase inhibitor protein expression on suppression of prostate cancer metastasis. , 2003, Journal of the National Cancer Institute.

[79]  P. Steeg.  Metastasis suppressors alter the signal transduction of cancer cells , 2003, Nature Reviews Cancer.

[80]  K. Arden,et al.  Functional genomic comparison of lineage-related human bladder cancer cell lines with differing tumorigenic and metastatic potentials by spectral karyotyping, comparative genomic hybridization, and a novel method of positional expression profiling. , 2002, Cancer research.

[81]  C. Moskaluk,et al.  RhoGDI2 is an invasion and metastasis suppressor gene in human cancer. , 2002, Cancer research.

[82]  D. Morrison,et al.  Nm23-H1 Metastasis Suppressor Phosphorylation of Kinase Suppressor of Ras via a Histidine Protein Kinase Pathway* , 2002, The Journal of Biological Chemistry.

[83]  I. Macdonald,et al.  Metastasis: Dissemination and growth of cancer cells in metastatic sites , 2002, Nature Reviews Cancer.

[84]  Yi-Hsin Wu,et al.  Activation of Antimetastatic Nm23-H1 Gene Expression by Estrogen and Its α-Receptor. , 2002, Endocrinology.

[85]  H.-L. Chen,et al.  Transfection of the nm23-H1 gene into human hepatocarcinoma cell line inhibits the expression of sialyl Lewis X, α1,3 fucosyltransferase VII, and metastatic potential , 2002, Journal of Cancer Research and Clinical Oncology.

[86]  Yi-Hsin Wu,et al.  Activation of antimetastatic Nm23-H1 gene expression by estrogen and its alpha-receptor. , 2002, Endocrinology.

[87]  E. Salamon,et al.  Adjuvant high-dose medroxyprogesterone acetate for early breast cancer: 13 years update in a multicentre randomized trial , 2001, British Journal of Cancer.

[88]  Careen K. Tang,et al.  Overexpression of KAI1 suppresses in vitro invasiveness and in vivo metastasis in breast cancer cells. , 2001, Cancer research.

[89]  O. Nishimura,et al.  Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptor , 2001, Nature.

[90]  Ximing J. Yang,et al.  Mitogen-activated protein kinase kinase 4 metastasis suppressor gene expression is inversely related to histological pattern in advancing human prostatic cancers. , 2001, Cancer research.

[91]  C. Osborne,et al.  Elevation of breast carcinoma Nm23-H1 metastasis suppressor gene expression and reduced motility by DNA methylation inhibition. , 2001, Cancer research.

[92]  E. Robertson,et al.  Epstein-Barr virus nuclear protein EBNA-3C interacts with the human metastatic suppressor Nm23-H1: A molecular link to cancer metastasis , 2001, Nature Medicine.

[93]  J. Jager,et al.  Adjuvant chemo-hormonal therapy with cyclophosphamide, doxorubicin and 5-fluorouracil (CAF) with or without medroxyprogesterone acetate (MPA) for node-positive cancer patients, update at 12 years follow up. , 2001, Breast.

[94]  Christopher W. Wong,et al.  Apoptosis: an early event in metastatic inefficiency. , 2001, Cancer research.

[95]  T. Nakajima,et al.  Mutation and expression of the metastasis suppressor gene KAI1 in esophageal squamous cell carcinoma , 2000, Cancer.

[96]  E. Odintsova,et al.  Attenuation of EGF receptor signaling by a metastasis suppressor, the tetraspanin CD82/KAI-1 , 2000, Current Biology.

[97]  T. Mashimo,et al.  Activation of the tumor metastasis suppressor gene, KAI1, by etoposide is mediated by p53 and c-Jun genes. , 2000, Biochemical and biophysical research communications.

[98]  I. Macdonald,et al.  Temporal progression of metastasis in lung: cell survival, dormancy, and location dependence of metastatic inefficiency. , 2000, Cancer research.

[99]  Hui-li Chen,et al.  Effects of all-trans retinoic acid and epidermal growth factor on the expression of nm23-H1 in human hepatocarcinoma cells , 2000, Journal of Cancer Research and Clinical Oncology.

[100]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[101]  I. Macdonald,et al.  Clinical targets for anti-metastasis therapy. , 2000, Advances in cancer research.

[102]  W. Kolch,et al.  Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP , 1999, Nature.

[103]  S. Aaronson,et al.  Inhibition of tumor cell growth by RTP/rit42 and its responsiveness to p53 and DNA damage. , 1998, Cancer research.

[104]  K. Miura,et al.  The expression of the KAI1 gene, a tumor metastasis suppressor, is directly activated by p53. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[105]  J. H. Lee,et al.  Suppression of metastasis in human breast carcinoma MDA-MB-435 cells after transfection with the metastasis suppressor gene, KiSS-1. , 1997, Cancer research.

[106]  J. Roth,et al.  Gene therapy for cancer: what have we done and where are we going? , 1997, Journal of the National Cancer Institute.

[107]  J M Trent,et al.  KiSS-1, a novel human malignant melanoma metastasis-suppressor gene. , 1996, Journal of the National Cancer Institute.

[108]  W. Isaacs,et al.  Down-regulation of the KAI1 metastasis suppressor gene during the progression of human prostatic cancer infrequently involves gene mutation or allelic loss. , 1996, Cancer research.

[109]  H. Frierson,et al.  Molecular and immunological detection of circulating tumor cells and micrometastases from solid tumors. , 1996, Clinical chemistry.

[110]  Stephen Pulman,et al.  Building the Framework , 1996 .

[111]  S. Al-Sedairy,et al.  Effects of cytokine‐mediated modulation of nm23 expression on the invasion and metastatic behavior of B16F10 melanoma cells , 2006, International journal of cancer.

[112]  J. Barrett,et al.  KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. , 1995, Science.

[113]  P. Steeg,et al.  NME1 protein expression and loss of heterozygosity mutations in primary human breast tumors. , 1994, Journal of the National Cancer Institute.

[114]  H. Höfler,et al.  E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. , 1994, Cancer research.

[115]  B. Weissman,et al.  Microcell-mediated transfer of chromosome 6 into metastatic human C8161 melanoma cells suppresses metastasis but does not inhibit tumorigenicity. , 1994, Oncogene.

[116]  P. Steeg,et al.  Transfection of human nm23-H1 into the human MDA-MB-435 breast carcinoma cell line: effects on tumor metastatic potential, colonization and enzymatic activity. , 1993, Oncogene.

[117]  S. Banerjee,et al.  Mutation in the nm23 gene is associated with metastasis in colorectal cancer. , 1993, Cancer research.

[118]  M. Oshimura,et al.  Localization of metastasis suppressor gene(s) for prostatic cancer to the short arm of human chromosome 11. , 1992, Cancer research.

[119]  J. Isaacs,et al.  Genetic factors and suppression of metastatic ability of prostatic cancer. , 1991, Cancer research.

[120]  L. Liotta,et al.  Reduced tumor incidence, metastatic potential, and cytokine responsiveness of nm3-transfected melanoma cells , 1991, Cell.

[121]  L. Weiss,et al.  Metastatic inefficiency. , 1990, Advances in cancer research.

[122]  J E Talmadge,et al.  Evidence for a novel gene associated with low tumor metastatic potential. , 1988, Journal of the National Cancer Institute.

[123]  R. Huben,et al.  Haematogenous dissemination of cells from human renal adenocarcinomas. , 1988, British Journal of Cancer.

[124]  D. Paulson,et al.  Spontaneous metastasis of cells of the human prostate carcinoma cell line PC-3 in athymic nude mice. , 1982, The Journal of urology.

[125]  P. Gullino,et al.  Quantitation of cell shedding into efferent blood of mammary adenocarcinoma. , 1975, Cancer research.

[126]  I. Fidler,et al.  Selection of successive tumour lines for metastasis. , 1973, Nature: New biology.

[127]  I. Fidler,et al.  Metastasis: Quantitative Analysis of Distribution and Fate of Tumor Emboli Labeled With 125I-5-Iodo-2′ -deoxyuridine , 1970 .

[128]  Agnes W. O'Brien.  Seed and Soil , 1905, The Elementary School Teacher.